(Q41071699)

English

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).

scientific article

Statements

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). (English)
Massie BM
Berk MR
Brozena SC
Elkayam U
Plehn JF
Kukin ML
Packer M
Murphy BE
Neuberg GW
Steingart RM
1 August 1993
492-501

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit